Cargando…
Side effects related to systemic cancer treatment: are we changing the Promethean experience with molecularly targeted therapies?
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Multimed Inc.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528304/ https://www.ncbi.nlm.nih.gov/pubmed/18769606 |
_version_ | 1782158877101391872 |
---|---|
author | De Angelis, Carlo |
author_facet | De Angelis, Carlo |
author_sort | De Angelis, Carlo |
collection | PubMed |
description | |
format | Text |
id | pubmed-2528304 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Multimed Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-25283042008-09-03 Side effects related to systemic cancer treatment: are we changing the Promethean experience with molecularly targeted therapies? De Angelis, Carlo Curr Oncol Invited Editorial Multimed Inc. 2008-08 /pmc/articles/PMC2528304/ /pubmed/18769606 Text en 2008 Multimed Inc. |
spellingShingle | Invited Editorial De Angelis, Carlo Side effects related to systemic cancer treatment: are we changing the Promethean experience with molecularly targeted therapies? |
title | Side effects related to systemic cancer treatment: are we changing the Promethean experience with molecularly targeted therapies? |
title_full | Side effects related to systemic cancer treatment: are we changing the Promethean experience with molecularly targeted therapies? |
title_fullStr | Side effects related to systemic cancer treatment: are we changing the Promethean experience with molecularly targeted therapies? |
title_full_unstemmed | Side effects related to systemic cancer treatment: are we changing the Promethean experience with molecularly targeted therapies? |
title_short | Side effects related to systemic cancer treatment: are we changing the Promethean experience with molecularly targeted therapies? |
title_sort | side effects related to systemic cancer treatment: are we changing the promethean experience with molecularly targeted therapies? |
topic | Invited Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528304/ https://www.ncbi.nlm.nih.gov/pubmed/18769606 |
work_keys_str_mv | AT deangeliscarlo sideeffectsrelatedtosystemiccancertreatmentarewechangingtheprometheanexperiencewithmolecularlytargetedtherapies |